TREPROSTINIL
Drug
Sandoz Inc.
Total Payments
$25,855
Transactions
880
Doctors
513
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3,638 | 136 | 117 |
| 2023 | $7,584 | 238 | 178 |
| 2022 | $3,665 | 140 | 113 |
| 2021 | $1,699 | 64 | 57 |
| 2020 | $842.03 | 41 | 38 |
| 2019 | $8,050 | 243 | 153 |
| 2018 | $377.12 | 18 | 18 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,355 | 878 | 90.3% |
| Space rental or facility fees (teaching hospital only) | $2,500 | 2 | 9.7% |
Top Doctors Receiving Payments for TREPROSTINIL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Normal, IL | $2,500 | 2 |
| , MD | Cardiovascular Disease | Omaha, NE | $534.24 | 8 |
| , MD | Specialist | Pittsburgh, PA | $530.25 | 8 |
| , MD | Pulmonary Disease | Saint Louis, MO | $517.29 | 7 |
| , M.D | Pulmonary Disease | Weston, FL | $508.98 | 12 |
| , M.D | Pulmonary Disease | Cleveland, OH | $475.40 | 9 |
| , MD | Internal Medicine | Philadelphia, PA | $451.67 | 12 |
| , M.D | Pulmonary Disease | Louisville, KY | $383.66 | 5 |
| , D.O | Critical Care Medicine | Columbus, OH | $323.65 | 5 |
| , M.D | Pulmonary Disease | Dallas, TX | $310.70 | 4 |
| , MD | Pulmonary Disease | Saint Louis, MO | $291.47 | 5 |
| , MD | Pulmonary Disease | Phoenix, AZ | $258.47 | 7 |
| , M.D | Internal Medicine | Phoenix, AZ | $254.69 | 4 |
| , MD | Pulmonary Disease | Austell, GA | $250.90 | 15 |
| , MD | Internal Medicine | Fresno, CA | $216.76 | 5 |
| , MD | Internal Medicine | Oklahoma City, OK | $214.51 | 9 |
| , M.D | Pulmonary Disease | Phoenix, AZ | $210.20 | 4 |
| , MD | Internal Medicine | Saint Louis, MO | $196.13 | 2 |
| , MD | Critical Care Medicine | Rochester, NY | $192.84 | 3 |
| , M.D | Pulmonary Disease | San Francisco, CA | $180.72 | 3 |
| , MD | Pulmonary Disease | Phoenix, AZ | $179.88 | 8 |
| , MD | Cardiovascular Disease | Brookfield, WI | $176.52 | 2 |
| , MD | Critical Care Medicine | Phoenix, AZ | $172.60 | 5 |
| , MD | Internal Medicine | Houston, TX | $172.42 | 9 |
| , M.D | Internal Medicine | Boston, MA | $168.99 | 4 |
Ad
Manufacturing Companies
- Sandoz Inc. $25,855
Product Information
- Type Drug
- Total Payments $25,855
- Total Doctors 513
- Transactions 880
About TREPROSTINIL
TREPROSTINIL is a drug associated with $25,855 in payments to 513 healthcare providers, recorded across 880 transactions in the CMS Open Payments database. The primary manufacturer is Sandoz Inc..
Payment data is available from 2018 to 2024. In 2024, $3,638 was paid across 136 transactions to 117 doctors.
The most common payment nature for TREPROSTINIL is "Food and Beverage" ($23,355, 90.3% of total).